文献
J-GLOBAL ID:201802217917515387
整理番号:18A1716644
ポルトガルにおけるトリメタジジン利用に対するヨーロッパ医薬品の制限の影響【JST・京大機械翻訳】
Effect of European Medicines Agency’s restrictions on trimetazidine utilization in Portugal
著者 (6件):
Pinto Daniel
(Group for Independent Academic Information, Chronic Diseases Research Center, NOVA Medical School, Lisbon, Portugal)
,
Silva Ana
(Regulatory Affairs Specialist Fellow, Lisbon, Portugal)
,
Heleno Bruno
(Group for Independent Academic Information, Chronic Diseases Research Center, NOVA Medical School, Lisbon, Portugal)
,
Rodrigues David Silverio
(Group for Independent Academic Information, Chronic Diseases Research Center, NOVA Medical School, Lisbon, Portugal)
,
Santos Isabel
(Group for Independent Academic Information, Chronic Diseases Research Center, NOVA Medical School, Lisbon, Portugal)
,
Caetano Pedro A.
(Group for Independent Academic Information, Chronic Diseases Research Center, NOVA Medical School, Lisbon, Portugal)
資料名:
Pharmacoepidemiology and Drug Safety
(Pharmacoepidemiology and Drug Safety)
巻:
27
号:
9
ページ:
962-968
発行年:
2018年
JST資料番号:
W0540A
ISSN:
1053-8569
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)